| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |